Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Stage 1 results of a phase II trial (AGMT MBC-6)

Gabriel Rinnerthaler; Simon Peter Gampenrieder; M Fridrik; A Petzer; M Hubalek; E Petru; T Jager; J Andel; M Balic; H Ulmer; Brigitte Mlineritsch; Richard Greil

doi:10.1158/1538-7445.SABCS15-P1-13-10

Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Stage 1 results of a phase II trial (AGMT MBC-6)

Gabriel Rinnerthaler, Simon Peter Gampenrieder, M Fridrik, A Petzer, M Hubalek, E Petru, T Jager, J Andel, M Balic, H Ulmer, Brigitte Mlineritsch, Richard Greil

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center
Department of Surgery

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Journal	CANCER RESEARCH
Volume	76
DOIs	https://doi.org/10.1158/1538-7445.SABCS15-P1-13-10
Publication status	Published - 2016
Event	38th Annual CTRC-AACR San Antonio Breast Cancer Symposium - San Antonio, TX Duration: 8 Dec 2015 → 12 Dec 2015

Access to Document

10.1158/1538-7445.SABCS15-P1-13-10

Cite this

Rinnerthaler, G., Gampenrieder, S. P., Fridrik, M., Petzer, A., Hubalek, M., Petru, E., Jager, T., Andel, J., Balic, M., Ulmer, H., Mlineritsch, B., & Greil, R. (2016). Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Stage 1 results of a phase II trial (AGMT MBC-6). CANCER RESEARCH , 76. https://doi.org/10.1158/1538-7445.SABCS15-P1-13-10

Rinnerthaler, Gabriel ; Gampenrieder, Simon Peter ; Fridrik, M et al. / Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Stage 1 results of a phase II trial (AGMT MBC-6). In: CANCER RESEARCH 2016 ; Vol. 76.

@article{b75fde8e7f0c436d823b925fd971c19d,

title = "Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Stage 1 results of a phase II trial (AGMT MBC-6)",

author = "Gabriel Rinnerthaler and Gampenrieder, \{Simon Peter\} and M Fridrik and A Petzer and M Hubalek and E Petru and T Jager and J Andel and M Balic and H Ulmer and Brigitte Mlineritsch and Richard Greil",

year = "2016",

doi = "10.1158/1538-7445.SABCS15-P1-13-10",

language = "English",

volume = "76",

journal = "CANCER RESEARCH ",

issn = "0008-5472",

publisher = "Amer Assoc Cancer Research",

note = "38th Annual CTRC-AACR San Antonio Breast Cancer Symposium ; Conference date: 08-12-2015 Through 12-12-2015",

}

Rinnerthaler, G , Gampenrieder, SP, Fridrik, M, Petzer, A, Hubalek, M, Petru, E, Jager, T, Andel, J, Balic, M, Ulmer, H, Mlineritsch, B & Greil, R 2016, 'Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Stage 1 results of a phase II trial (AGMT MBC-6)', CANCER RESEARCH , vol. 76. https://doi.org/10.1158/1538-7445.SABCS15-P1-13-10

Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Stage 1 results of a phase II trial (AGMT MBC-6). / Rinnerthaler, Gabriel ; Gampenrieder, Simon Peter; Fridrik, M et al.
In: CANCER RESEARCH , Vol. 76, 2016.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Stage 1 results of a phase II trial (AGMT MBC-6)

AU - Rinnerthaler, Gabriel

AU - Gampenrieder, Simon Peter

AU - Fridrik, M

AU - Petzer, A

AU - Hubalek, M

AU - Petru, E

AU - Jager, T

AU - Andel, J

AU - Balic, M

AU - Ulmer, H

AU - Mlineritsch, Brigitte

AU - Greil, Richard

PY - 2016

Y1 - 2016

U2 - 10.1158/1538-7445.SABCS15-P1-13-10

DO - 10.1158/1538-7445.SABCS15-P1-13-10

M3 - Abstract (Journal)

SN - 0008-5472

VL - 76

JO - CANCER RESEARCH

JF - CANCER RESEARCH

T2 - 38th Annual CTRC-AACR San Antonio Breast Cancer Symposium

Y2 - 8 December 2015 through 12 December 2015

ER -

Rinnerthaler G , Gampenrieder SP, Fridrik M, Petzer A, Hubalek M, Petru E et al. Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Stage 1 results of a phase II trial (AGMT MBC-6). CANCER RESEARCH . 2016;76. doi: 10.1158/1538-7445.SABCS15-P1-13-10